skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

9 Total results for product and free and sample content found

Biomedtracker

2021 Clinical Development Success Rates

03 Mar 2021

2021 Clinical Development Success Rates

This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.

Topic Clinical Trials Drug Development Landscape Drug Pricing

Pink Sheet

Biden Administration May Push Rx Pricing To Back Burner With Senate That Stays Pharma Friendly

By Cathy Kelly 18 Nov 2020

Biden Administration Rx Pricing

A Biden Administration with near-term priorities other than drug pricing and a Republican-controlled Senate dedicated to blocking any legislation that would enact government price controls is a relatively positive outcome for industry

Topic US Election 2020 Drug Pricing

Pink Sheet

Biden, Germany And Bringing A National Drug Pricing Negotiation Process To US

By Cathy Kelly 17 Nov 2020

Biden US Election 2020 final debate

Germany uses government facilitated price negotiations between publicly funded insurers and manufacturers that are based on an independent assessment of how much added value a drug provides.

Topic US Election 2020 Drug Pricing

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 02 Oct 2020

Scrip August Podcast

Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.

Topic Clinical Trials Drug Pricing Research & Development

Pink Sheet

Six Pharma CEOs To Testify In House as Democrats, Trump Compete For Attention On Drug Pricing

By Sarah Karlin-Smith 25 Sep 2020

US Election Drug Pricing Debate

While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.

Topic US Election 2020 Drug Pricing

Pink Sheet

Biden's Drug Pricing Administrative Actions Could Focus On Medicare Demos

By Cathy Kelly 25 Sep 2020

Joe Biden Drug Pricing

Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.

Topic US Election 2020 Drug Pricing

Pink Sheet

Biopharma Needs A Deal On Drug Pricing As Shield Against Possible Democrat Wins - BIO's Greenwood

By Cathy Kelly 21 Sep 2020

US Election Drug Pricing Shielding

Outgoing Biotechnology Innovation Organization CEO suggests consideration of price inflation caps instead of 'big discounts' in Medicare Part D and says that industry should fund a cap on beneficiary out-of-pocket costs in the program.

Topic US Election 2020 Drug Pricing Legislation

Scrip, Pink Sheet

Drug Pricing Update: Strategies and Trends

04 Jun 2020

Drug pricing update: strategies and trends

For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Scrip. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours. 

Topic Drug Pricing

Pink Sheet, Scrip

Top 5 Drug Pricing Insights and Policies

04 Jun 2020

Top 5 drug pricing insights and policies

For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Pink Sheet. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours.

Topic Drug Pricing

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: